![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication August 4, 2006.
Revised September 18, 2006.
Accepted for publication September 19, 2006.
Our previous studies have suggested a role for AMP-activated protein kinase (AMPK) in the induction of CYP2B6 by PB (PB) in hepatoma-derived cells (Rencurel et al.,2005). Here, we show in primary human hepatocytes that: 1) 5'-phosphoribosyl-5-aminoimidazol-4-carboxamide 1-beta-D-ribofuranoside (AICAR) and the biguanide metformin, known activators of AMPK, dose-dependently increase the expression of CYP2B6 and CYP3A4 to a similar extent as does PB. 2) Phenobarbital, but not the human nuclear receptor constitutive active/androstane receptor (CAR) ligand 6-(4-chlorophenyl)imidazol[2,1-6][1,3]thiazole-5-carbaldehyde (CITCO), dose-dependently increase AMPK activity. 3) Pharmacological inhibition of AMPK activity with compound C or dominant-negative forms of AMPK blunt the inductive response to phenobarbital. Furthermore, in transgenic mice with a liver-specific deletion of both the 
1 and 2 AMPK catalytic subunits, basal levels of Cyp2b10 and Cyp3a11 mRNA were increased but not in primary culture of mouse hepatocytes. However, phenobarbital or 1,4 bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP), a mouse CAR ligand, failed to induce the expression of these genes in the liver or cultured hepatocytes from mice lacking hepatic expression of the 1 and 2 subunits of AMPK. The distribution of CAR between the nucleus and cytosol was not altered in hepatocytes from mice lacking both AMPK catalytic subunits. These data highlight the essential role of AMPK in the CAR-mediated signal transduction pathway.
Key words:
Phosphorylation/Dephosphorylation, Regulation of gene expression, Cytochrome P450, Regulation - xenobiotic
This article has been cited by other articles:
|
|
 |
|
  N. M. Jackson and T. A. Kocarek Suppression of CYP2B Induction by Alendronate-Mediated Farnesyl Diphosphate Synthase Inhibition in Primary Cultured Rat Hepatocytes Drug Metab. Dispos., October 1, 2008; 36(10): 2030 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Roth, R. Looser, M. Kaufmann, S. M. Blattler, F. Rencurel, W. Huang, D. D. Moore, and U. A. Meyer Regulatory Cross-Talk between Drug Metabolism and Lipid Homeostasis: Constitutive Androstane Receptor and Pregnane X Receptor Increase Insig-1 Expression Mol. Pharmacol., April 1, 2008; 73(4): 1282 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gehlhaus, N. Schmitt, B. Volk, and R. P. Meyer Antiepileptic Drugs Affect Neuronal Androgen Signaling via a Cytochrome P450-Dependent Pathway J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 550 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Koike, R. Moore, and M. Negishi Extracellular Signal-Regulated Kinase Is an Endogenous Signal Retaining the Nuclear Constitutive Active/Androstane Receptor (CAR) in the Cytoplasm of Mouse Primary Hepatocytes Mol. Pharmacol., May 1, 2007; 71(5): 1217 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Blattler, F. Rencurel, M. R. Kaufmann, and U. A. Meyer In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase PNAS, January 16, 2007; 104(3): 1045 - 1050. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
